by vyc | Dec 1, 2010 | Commentary |
In November 2010, the U.S. Food and Drug Administration (FDA) gave clearance for Advanced Cell Technology (ACT), based in Marlborough, Massachusetts, to commence Phase I/II clinical trials of a new therapy for Stargardt’s Macular Dystrophy, an incurable form of...
by vyc | Jan 9, 2010 | Commentary |
On December 24, 2009, the Senate passed a landmark health care reform bill. Included within the Patient Protection and Affordable Care Act is the Biologics Price Competition and Innovation Act, which contains provisions for the regulation of cheaper versions of...
